World FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis – Contract Pharma Last updated: April 14, 2026 9:31 pm Editorial Staff 3 days ago Share SHARE FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis Contract Pharmasource Man, 72, killed in Marysville collision with semitruck – The Seattle Times Fuel relief boost for care workers amid New Zealand price pressure – Sky News Australia What to watch at this year's CU Boulder Conference on World Affairs – Axios The Latest: Iran launches missiles at Israel and Gulf states as explosions heard around Tehran – KSAT University of Colorado Boulder to host Conference on World Affairs – denvergazette.com Share This Article Facebook Email Print Previous Article Trump again rejects Colorado amid accusations of playing politics with disaster aid – Newsday Next Article Times Opinion: Vaccine confusion sets up US for a resurgence of hepatitis B in babies – Chattanooga Times Free Press Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
